Omidenepag isopropyl Uses, Dosage, Side Effects and more
Omidenepag isopropyl is under investigation in clinical trial NCT02179008 (Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension).
| Attribute | Details |
|---|---|
| Trade Name | Omidenepag isopropyl |
| Generic | Omidenepag isopropyl |
| Omidenepag isopropyl Other Names | Omidenepag isopropyl |
| Type | |
| Formula | C26H28N6O4S |
| Weight | Average: 520.61 Monoisotopic: 520.18927458 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Omidenepag isopropyl is an agonist of the prostaglandin EP2 receptor indicated in the treatment of glaucoma.
Omidenepag isopropyl is also used to associated treatment for these conditions: Glaucoma
